The Rush Alzheimer's Disease Center is currently conducting a study which is open to people in late stages of dementia and other illnesses. You might have a family member or friend who would be appropriate.
The research study is on an experimental PET imaging compound.
What is the purpose of this study?
The purpose of the study is to test how well this compound works in detecting brain amyloid, a protein associated with Alzheimer's disease. The compound my highlight amyloid deposits in pictures taken of the brain using positron emission tomography (PET) scanner. These results will be compared with brain autopsy findings upon death.
What will you be asked to do?
All eligible participants will undergo initial MRI and PET scans with potential follow-up visits for up to 2 years and agree to brain donation. Every year participants will receive a single injection of the study compound prior to undergoing the PET scan of their brain.
To be eligible to participate in this study, you must be:
There is no cost to join the study. The study compound and all study-related procedures will be covered by the research study. The study is sponsored by Navidea Biopharmaceuticals.
For more information or to volunteer, please contact:
Mary Messenger at (312) 942-6514
Be prepared to leave a message stating your name, telephone number and best time to be reached.
Click here for a PDF of the flyer from the Rush Alzheimer's Disease Center.